Anthony Clarke's most recent trade in Achieve Life Sciences Inc. was a trade of 1,000 Performance Restricted Stock Unit (PRSU) done . Disclosure was reported to the exchange on April 28, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Achieve Life Sciences Inc. | Anthony Clarke | CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 1,000 | 1,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
Achieve Life Sciences Inc. | Anthony Clarke | CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 1,000 | 3,752 (0%) | 0% | 0 | Common Stock | |
Achieve Life Sciences Inc. | Anthony Clarke | CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.43 per share. | 28 Apr 2022 | 250 | 3,502 (0%) | 0% | 7.4 | 1,858 | Common Stock |
Achieve Life Sciences Inc. | Anthony Clarke | CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 7,500 | 7,500 | - | - | Performance Restricted Stock Unit (PRSU) | |
Achieve Life Sciences Inc. | Anthony Clarke | CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
Achieve Life Sciences Inc. | Anthony Clarke | CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
Achieve Life Sciences Inc. | Anthony Clarke | CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 2,000 | 2,000 | - | - | Performance Restricted Stock Unit (PRSU) |